# Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

> **NCT01874769** · — · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 30 (actual)

## Conditions studied

- Recessive Dystrophic Epidermolysis Bullosa

## Interventions

- **OTHER:** Blood collection
- **OTHER:** Skin biopsies

## Key facts

- **NCT ID:** NCT01874769
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01874769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01874769, "Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01874769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*